Chronic thromboembolic pulmonary hypertension – surgical treatment options and our experience
Povzetek
Background: Chronic thromboembolic pulmonary hypertension is an increasingly recognized cause of pulmonary hypertension. Th e prognosis of untreated patients is poor. Th e treatment of choice is the potentially curative pulmonary endarterectomy, which is feasible in more than half of the cases. Th e advances in operative techniques make pulmonary endarterectomy possible even in patients with very peripheral thromboemboli in the subsegmental arteries. Due to rarity of the disease it is advisable to perform the procedure in experienced specialized centers with high frequency of operations and thus low perioperative risk. Patients with persistent pulmonary hypertension aft er surgery and patients who have inoperable disease can be treated with vasodilators and remodulators of pulmonary vasculature, which improve prognosis to some extent. Th e fi nal treatment option is lung transplantation. Conclusions: Patients with chronic tromboembolic pulmonary hypertension have to be evaluated by a consultant surgeon with experience in pulmonary endarterectomy. In the last year two Slovenian patients were referred from our clinic to the University hospital in Vienna for pulmonary endarterectomy. Th e treatment was successful with good followup results.Prenosi
Prenosi
Objavljeno
Številka
Rubrika
Licenca
Avtor na prispevku, ki ga bo pripravil za Zdravniški vestnik, po pogodbi nanj prenaša vse materialne avtorske pravice, kakor izhajajo iz 22. člena Zakona o avtorski in sorodnih pravicah, in sicer pravico reproduciranja, pravico javnega izvajanja, pravico javnega prenašanja, pravico javnega predvajanja s fonogrami in videogrami, pravico javnega prikazovanja, pravico radiodifuznega oddajanja, pravico radiodifuzne retransmisije, pravico sekundarnega radiodifuznega oddajanja, pravico dajanja na voljo javnosti, pravico predelave, pravico avdiovizualne priredbe, pravico distribuiranja ter pravico dajanja v najem in vse druge pravice avtorja v skladu z ZASP.
Avtorjev prenos pravic po pogodbi je neizključen, velja za neomejeno število izdaj, za ves čas trajanja materialnih avtorskih pravic ter je prostorsko neomejen.
Avtor sme avtorsko delo tudi sam izkoriščati ali avtorske pravice prenašati na tretje osebe, vendar oboje šele po preteku 3 mesecev od prve objave dela v reviji Zdravniški vestnik.
Avtor Zdravniškemu vestniku izrecno dovoli, da lahko pravice, pridobljene v skladu s pogodbo prenaša naprej na tretje osebe brez omejitev.
Avtor se strinja, da Zdravniški vestnik prispevek objavi pod pogoji licence Creative Commons BY-NC 4.0 (navedba avtorstva-nekomercialno) ali primerljive licence.